<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Cugno G</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Hidradenitis suppurativa (HS) is a painful and disfiguring chronic inflammatory skin disease. Despite many efforts over the past decade to improve the care of patients with HS, their satisfaction with medical care remains limited.&lt;h4>Aim&lt;/h4>The aim of this study was to assess the perceived involvement of patients with HS and, for comparison, patients with psoriasis, in treatment decision-making and to identify areas associated with positive perception.&lt;h4>Methods&lt;/h4>A prospective, cross-sectional, questionnaire-based survey was conducted between May 2023 and July 2024 in different types of dermatological care facilities in Germany. Patients rated their therapy decision involvement and treatment satisfaction on a 0-10 scale. Data were stratified by demographic, clinical</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>1626345</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12440716</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Patient involvement in treatment decisions is associated with increased therapy satisfaction in Hidradenitis suppurativa.</pubmed_title><pmcid>PMC12440716</pmcid><pubmed_authors>Asadullah K</pubmed_authors><pubmed_authors>Assaf K</pubmed_authors><pubmed_authors>Wolk K</pubmed_authors><pubmed_authors>Wilsmann-Theis D</pubmed_authors><pubmed_authors>Sabat R</pubmed_authors><pubmed_authors>Moessner R</pubmed_authors><pubmed_authors>Siddi V</pubmed_authors><pubmed_authors>Kromer C</pubmed_authors><pubmed_authors>Kokolakis G</pubmed_authors><pubmed_authors>Happ A</pubmed_authors><pubmed_authors>Schneider LC</pubmed_authors><pubmed_authors>Schneider-Burrus S</pubmed_authors><pubmed_authors>Abu Rached N</pubmed_authors><pubmed_authors>Friedrich M</pubmed_authors><pubmed_authors>Cugno G</pubmed_authors><pubmed_authors>Groß D</pubmed_authors><pubmed_authors>Bechara FG</pubmed_authors><pubmed_authors>Peitsch WK</pubmed_authors><pubmed_authors>Kubitzki D</pubmed_authors><pubmed_authors>Vandersee S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient involvement in treatment decisions is associated with increased therapy satisfaction in Hidradenitis suppurativa.</name><description>&lt;h4>Background&lt;/h4>Hidradenitis suppurativa (HS) is a painful and disfiguring chronic inflammatory skin disease. Despite many efforts over the past decade to improve the care of patients with HS, their satisfaction with medical care remains limited.&lt;h4>Aim&lt;/h4>The aim of this study was to assess the perceived involvement of patients with HS and, for comparison, patients with psoriasis, in treatment decision-making and to identify areas associated with positive perception.&lt;h4>Methods&lt;/h4>A prospective, cross-sectional, questionnaire-based survey was conducted between May 2023 and July 2024 in different types of dermatological care facilities in Germany. Patients rated their therapy decision involvement and treatment satisfaction on a 0-10 scale. Data were stratified by demographic, clinical</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-03T10:13:34.333Z</modification><creation>2026-04-26T03:11:53.787Z</creation></dates><accession>S-EPMC12440716</accession><cross_references><pubmed>40969796</pubmed><doi>10.3389/fmed.2025.1626345</doi></cross_references></HashMap>